Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BIOeCON is an industrial biotechnology company that develops proprietary technology for the conversion of biomass into renewable chemicals and fuels. The company is best known for its 'Bioliq' and molten salt hydrate processes, which efficiently break down lignocellulosic materials into platform chemicals such as levulinic acid. BIOeCON's business model focuses on licensing its intellectual property and forming strategic partnerships with global energy and chemical companies. By providing sustainable alternatives to fossil-based feedstocks, the company plays a significant role in the advancement of the global bio-economy. Its innovations have applications across various sectors, including specialty chemicals and potential pharmaceutical intermediates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BIOeCON.